Search
Advanced search

Company search

Company/VAT no/Free text Country/City/Municipality

TURNOVER (x1000 SEK)

NET PROFIT (x1000 SEK)

Share

Xellia Pharmaceuticals AS

Closing information (x1000 SEK)

Closing information 2024/12 2023/12 2022/12
Turnover 80,622 More Arrow 84,767 More Arrow 94,082
Financial expenses 3 More Arrow 13 Less Arrow 3
Earnings before taxes 83,619 Less Arrow 49,958 More Arrow 55,076
Total assets 757,606 Less Arrow 722,814 Less Arrow 719,770
Current assets 254,016 Less Arrow 240,862 Less Arrow 225,223
Current liabilities 69,064 Less Arrow 53,728 Less Arrow 19,767
Equity capital 685,743 Less Arrow 665,759 More Arrow 696,200
- share capital 216,482 More Arrow 220,385 More Arrow 236,023

Financial ratios

Fiscal year 2024/12 2023/12 2022/12
Solvency 90.5% More Arrow 92.1% More Arrow 96.7%
Turnover per employee
Profit as a percentage of turnover 103.7% Less Arrow 58.9% Less Arrow 58.5%
Return on assets (ROA) 11.0% Less Arrow 6.9% More Arrow 7.7%
Current ratio 367.8% More Arrow 448.3% More Arrow 1139.4%
Return on equity (ROE) 12.2% Less Arrow 7.5% More Arrow 7.9%
Change turnover -2,644 Less Arrow -3,081 More Arrow 16,640
Change turnover % -3% Less Arrow -4% More Arrow 21%
Chg. No. of employees
Chg. No. of employees %

Total value of public sale

Fiscal year 2024/12 2023/12 2022/12
Total value of public sale 0 Equal arrow 0 Equal arrow 0

Closing figures are converted to the currency above at the exchange rate of the closing date. Source for the exchange rates: Sveriges Riksbank

The closing information is gathered directly from the companies or from Creditsafe.